Yüklüyor......

The Latest Innovations in the Drug Pipeline for Multiple Sclerosis

Several new medications are being investigated in late-phase studies for the treatment of patients with relapsing or progressive multiple sclerosis (MS). These agents represent a variety of mechanisms of action and provide not only lower relapse rates but also improvement in disabilities. The majori...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am Health Drug Benefits
Asıl Yazarlar: Radick, Lea, Mehr, Stanton R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Engage Healthcare Communications, LLC 2015
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4684635/
https://ncbi.nlm.nih.gov/pubmed/26702336
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!